The Division of Rheumatology strives to understand more about Spondyloarthritis through
research. Please see the list below, which summarizes the studies available to individuals interested in
advancing our understanding and treatment of rheumatic disease.
|Program for individuals
with an Elevated Risk
Liron Caplan, MD
study of individuals
at risk of spondyloarthritis (SpA).
This study does not
include a placebo group.
|1) Parent, child, or sibling
(by blood) of
2) Individuals with SpA
or SpA associated
conditions such as
disease, psoriasis, or
Please note that study status changes frequently and therefore, a listed study may not be actively
enrolling. Also, the complete list of inclusion and exclusion criteria for a given study is often not listed
due to its length. A visit to determine an individual’s eligibility may be required. A placebo is an inactive
substance or treatment that looks the same as, and is given the same way as, an active drug or
treatment being tested. The effects of the active drug or treatment are compared to the effects of the